Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.04% |
| 2 | Healthcare | 13.57% |
| 3 | Technology | 12.05% |
| 4 | Financials | 10.74% |
| 5 | Consumer Discretionary | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HES
2401
PUT
DELISTED
Hess
HES
| $1.95M | ﹤0.01% |
+32,400
| New | +$1.78M |
|
|
PAYA
2402
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $1.95M | ﹤0.01% |
+200,000
| New | +$1.94M |
|
2403
CALL
T-Mobile US
TMUS
$191B
| $1.95M | ﹤0.01% |
+28,200
| New | +$1.97M |
|
2404
eGain
EGAN
$205M
| $1.94M | ﹤0.01% |
+185,951
| New | +$1.76M |
|
2405
Medpace
MEDP
$17.1B
| $1.94M | ﹤0.01% |
32,933
-236,693
| -88% | -$14.1M |
|
2406
Northwest Bancshares
NWBI
$2.25B
| $1.94M | ﹤0.01% |
+114,044
| New | +$2.02M |
|
|
PR
2407
Permian Resources
PR
$19.4B
| $1.93M | ﹤0.01% |
219,989
+209,885
| +2,077% | +$2.38M |
|
2408
Hudbay
HBM
$13.5B
| $1.93M | ﹤0.01% |
270,530
-267,588
| -50% | -$1.66M |
|
|
MAGN
2409
Magnera Corp
MAGN
$439M
| $1.93M | ﹤0.01% |
+10,520
| New | +$1.77M |
|
|
AIV
2410
Aimco
AIV
$365M
| $1.93M | ﹤0.01% |
287,541
-5,939,210
| -95% | -$38.3M |
|
2411
ADT
ADT
$5.45B
| $1.92M | ﹤0.01% |
301,068
-8,979
| -3% | -$64.8K |
|
2412
F5
FFIV
$23.2B
| $1.92M | ﹤0.01% |
12,263
+8,888
| +263% | +$1.43M |
|
2413
PUT
FedEx
FDX
$78.4B
| $1.92M | ﹤0.01% |
+10,600
| New | +$1.87M |
|
2414
General Mills
GIS
$21.6B
| $1.92M | ﹤0.01% |
37,100
-187,999
| -84% | -$8.51M |
|
2415
PUT
Boston Scientific
BSX
$67.6B
| $1.92M | ﹤0.01% |
50,000
| – | – |
|
|
YI
2416
111 Inc
YI
$30.4M
| $1.92M | ﹤0.01% |
29,541
+6,861
| +30% | +$554K |
|
|
SHI
2417
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
| $1.92M | ﹤0.01% |
40,130
-47,196
| -54% | -$2.29M |
|
2418
Great Southern Bancorp
GSBC
$856M
| $1.9M | ﹤0.01% |
36,667
-4,064
| -10% | -$216K |
|
2419
NETSCOUT
NTCT
$2.87B
| $1.9M | ﹤0.01% |
67,761
-48,368
| -42% | -$1.28M |
|
2420
Stock Yards Bancorp
SYBT
$2.48B
| $1.9M | ﹤0.01% |
56,229
+39,511
| +236% | +$1.38M |
|
2421
Avery Dennison
AVY
$13.5B
| $1.89M | ﹤0.01% |
16,726
-119,387
| -88% | -$12.3M |
|
|
DRNA
2422
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.89M | ﹤0.01% |
128,877
+5,454
| +4% | +$62.7K |
|
|
PVLA
2423
Palvella Therapeutics
PVLA
$2.17B
| $1.89M | ﹤0.01% |
7,040
-4,455
| -39% | -$1.06M |
|
2424
Quanex
NX
$904M
| $1.89M | ﹤0.01% |
118,643
-270,065
| -69% | -$4.29M |
|
2425
International Money Express
IMXI
$438M
| $1.88M | ﹤0.01% |
161,610
+114,010
| +240% | +$1.29M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $10.1B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.